The current stock price of XSPA is 0.655 USD. In the past month the price decreased by -13.37%. In the past year, price decreased by -50.75%.
ChartMill assigns a fundamental rating of 5 / 10 to XSPA. XSPA has only an average score on both its financial health and profitability.
Over the last trailing twelve months XSPA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 88.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -3.55% | ||
| ROA | -3.28% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
7 analysts have analysed XSPA and the average price target is 2.04 USD. This implies a price increase of 211.45% is expected in the next year compared to the current price of 0.655.
For the next year, analysts expect an EPS growth of -814% and a revenue growth -2.07% for XSPA
XpresSpa Group, Inc. provides global travel health and wellness services. The company is headquartered in New York City, New York and currently employs 363 full-time employees. The company went IPO on 2010-06-18. The Company’s segments include XpresSpa, XpresTest and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment provides access to integrated care and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information. The firm operates in two geographical regions: United States and all other countries, which include Amsterdam, and Dubai.
XPRESSPA GROUP INC
254 West 31St Street, 11Th Floor
New York City NEW YORK 10001 US
CEO: Douglas Satzman
Employees: 363
Phone: 12123097549.0
XpresSpa Group, Inc. provides global travel health and wellness services. The company is headquartered in New York City, New York and currently employs 363 full-time employees. The company went IPO on 2010-06-18. The Company’s segments include XpresSpa, XpresTest and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment provides access to integrated care and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information. The firm operates in two geographical regions: United States and all other countries, which include Amsterdam, and Dubai.
The current stock price of XSPA is 0.655 USD. The price decreased by -5.65% in the last trading session.
XSPA does not pay a dividend.
XSPA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
7 analysts have analysed XSPA and the average price target is 2.04 USD. This implies a price increase of 211.45% is expected in the next year compared to the current price of 0.655.
XPRESSPA GROUP INC (XSPA) has a market capitalization of 61.58M USD. This makes XSPA a Micro Cap stock.